India closer to dengue vaccine as final trial underwayPROMISING: DengiAll would become one of the world’s first single-dose dengue vaccines, and could become an affordable dengue vaccine for lower-income countriesAFP, NEW DELHIAs dengue surges globally, an Indian vaccine candidate has entered the final stage of testing, raising hopes for one of the world’s first single-dose shots against the deadly mosquito-borne disease. In India, final approval would come from the Drugs Controller General of India, while WHO prequalification would be required for large-scale international use. Experts said a successful Indian vaccine could be key to affordability and mass rollout in lower-income countries. Still, he cautioned that only phase three results would determine whether a candidate meets the criteria for a safe and effective dengue vaccine. “Only then can we have a useful dengue vaccine.

Source: Taipei Times February 27, 2026 16:17 UTC